GET THE APP

Efficacy of Paclitaxel and S-1 in a Patient with Advanced Ps | 20661

பொது மருத்துவம்: திறந்த அணுகல்

ஐ.எஸ்.எஸ்.என் - 2327-5146

சுருக்கம்

Efficacy of Paclitaxel and S-1 in a Patient with Advanced Pseudomyxoma Peritonei Concomitant with Gastric Cancer

Yukako Mokutani, Junichi Nishimura, Mamoru Uemura, Naotsugu Haraguchi, Tarou Hayashi, Taishi Hata, Ichiro Takemasa, Tsunekazu Mizushima, Masanori KishibuchI, Hirofumi Yamamoto, Yuichiro Doki and Masaki Mori

Pseudomyxoma Peritonei (PMP) is a rare disease characterized by disseminated intra-peritoneal implants and mucinous ascites.There is currently no standard treatment strategy for PMP. Presentation of case: We present an unusual case of advanced PMP concomitant with early gastric cancer in a 61-year-old male. In the first operation, in December 2007, the gastric cancer was unrespectable by extensive dissemination of PMP. Therefore, cytoreductive surgery for PMP and appendectomy were performed. After systemic chemotherapy with paclitaxel (Taxo, PTX) plus S-1 for almost 1year, the dissemination on the stomach and intestines disappeared, and we were able to perform a subtotal gastrectomy to remove early gastric cancer. Afterwards, with the intermittent administration of irinotecan (CPT-11) in addition to the basal use of S-1, the patient survived more than five years. To the present day, systemic therapy is still being administered, and might lead to stabilization of disease.

மறுப்பு: இந்த சுருக்கமானது செயற்கை நுண்ணறிவு கருவிகளைப் பயன்படுத்தி மொழிபெயர்க்கப்பட்டது மற்றும் இன்னும் மதிப்பாய்வு செய்யப்படவில்லை அல்லது சரிபார்க்கப்படவில்லை